12 Nov Caeregen Therapeutics co-Founder Dr. Michael T. Trese Honored at the American Academy of Ophthalmology (AAO) 2021 Annual Meeting
2021 Laureate Award Recognizes Exceptional Contributions in Overcoming Vision Loss November 11, 2021, Rochester, MI and New Orleans, LA – Caeregen Therapeutics, LLC, a Michigan-based, regenerative medicine therapeutics company, today announced that company co-founder Dr. Michael T. Trese, received the prestigious Laureate Award from the American Academy...